[Use of etanercept in amyloidosis secondary to rheumatoid arthritis, a report of two cases]

Reumatol Clin. 2011 Nov-Dec;7(6):397-400. doi: 10.1016/j.reuma.2010.12.005. Epub 2011 Mar 21.
[Article in Spanish]

Abstract

Rheumatoid arthritis (RA) is one of the most common causes of AA amyloidosis. Most patients are asymptomatic and only when there are large deposits in certain organs, functional problems arise. We report two patients with amyloidosis secondary to RA, with renal and intestinal involvement, who responded to treatment with etanercept.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Amyloidosis / diagnosis
  • Amyloidosis / etiology*
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy*
  • Colonic Diseases / diagnosis
  • Colonic Diseases / etiology*
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Kidney Diseases / diagnosis
  • Kidney Diseases / etiology*
  • Male
  • Middle Aged
  • Receptors, Tumor Necrosis Factor / therapeutic use*

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Etanercept